semaglutide and dialysis in patients with kidney failure obesity undergoing and wishing to be transplanted: A prospective, observational, open‐label study - Vanek - 2024 - Diabetes, Obesity and Metabolism GLP‑1 in Advanced CKD Dialysis:

PDE5 inhibitors constitute the first-line treatment, while adjunctive TRT may be considered for hypogonadal non-responders, with careful attention to potential side effects, such as gastrointestinal symptoms, increased blood pressure, and thrombosis [206]

Most patients report noticeably reduced appetite within 35 days of starting semaglutide, with peak appetite suppression typically occurring 24 weeks into treatment

A reduction in testosterone levels often leads to muscle loss, which in turn lowers metabolic rate

If you're not sure what it is you're looking for or just want to browse, this setup makes the process more complicated than it needs to be

Taken as a collective, unstructured peer support is unlikely to help you more than a formal psychoeducation program would, the results suggest